Neoantigen cancer vaccine augments anti-CTLA-4 efficacy

Salvatori, E; Lione, L; Compagnone, M; Pinto, E; Conforti, A; Ciliberto, G; Aurisicchio, L; Palombo, F

Aurisicchio, L; Palombo, F (通讯作者),Takis, Rome, Italy.;Aurisicchio, L; Palombo, F (通讯作者),Neomatrix, Rome, Italy.;Aurisicchio, L (通讯作者),Ewivax, Rome, Italy.

NPJ VACCINES, 2022; 7 (1):

Abstract

Immune checkpoint inhibitors (ICI) based on anti-CTLA-4 (alpha CTLA-4) and anti-PD1 (alpha PD1) are being tested in combination with different therape......

Full Text Link